Californian biotech Jasper Therapeutics presented data from the 180mg cohort of the company’s SPOTLIGHT Phase Ib/IIa study of ...

Initial results from the ALXN1210-TMA-314 Phase III trial showed that UK pharma major AstraZeneca’s Ultomiris (ravulizumab) ...

With exports valued at 105.5 billion Swiss francs ($130.2 billion) and a 38.5% share of total exports, the pharmaceutical ...

A clinical-stage biotech company based in Redwood City, California, developing tissue-restorative biologics for chronic ...

A clinical-stage biotech company developing off-the-shelf, genetically unmodified T cell therapeutics for infectious diseases ...

As part of implementing President Trump’s Executive Order No. 14273, Lowering Drug Prices by Once Again Putting Americans First, US the Federal Trade Commission (FTC) and the Justice Department of ...

Notable research news last week included US biopharma Avidity Biosciences announcing a positive update on its muscular ...

US mRNA specialist Moderna today announced that the US Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345), ...

The International Finance Facility for Immunization (IFFIm) has announced the settlement of its £300 million ($407 million), ...

The US Food and Drug Administration (FDA) has notified KalVista Pharmaceutical that it will not meet the Prescription Drug ...

The Food and Drug Administration approved US pharma giant Merck & Co’s mega-blockbuster cancer drug Keytruda (pembrolizumab) ...

Germany’s Merck KGaA has presented detailed results from cohort B of the global Phase II WILLOW study of enpatoran, an ...